Head of Medical - CEE+

Job Description

The Head of Medical, CEE+ leads the CEE+ Medical Affairs agenda across affiliates, platform resources and partner markets. The role delivers strategic, scientific leadership and patient-centred value for external and internal stakeholders, in line with SOPs and Sobi Medical Playbook:

The role combines:

• About 40%: Hands-on asset leader. For the assigned asset, the Head of Medical personally owns the regional scientific agenda, working directly with affiliates and top KOLs. This follows the working model of the Medical Lead CEE role: translating Sobi strategy into scientific communication, KOL engagement, evidence generation and field execution.
• About 60%: Leader of the portfolio team. The Head of Medical builds, coaches and directs the CEE+ medical platform Medical Leads who are accountable for the remaining therapeutic areas in the Sobi portfolio, and ensures consistent standards, prioritisation and execution quality across affiliates and partner markets.

The role is a matrix leadership position. Success depends on partnership and stakeholder alignment around one coherent science agenda for CEE. The holder is expected to be agile, to anticipate change, and to bring clarity in a fast-moving environment.

Main responsibilities:

• Lead the development, resourcing, execution, and follow-up of CEE+ Medical Affairs plans and support affiliate  LMIP plans, aligned with global strategy, brand plans, launch priorities, partner-market needs, and business objectives, with 40% focus on driving designated asset & BD agenda
• Provide matrix medical leadership to CEE+ affiliates and partner markets, leading CEE+MLT, support CEERJ Medical Agenda (participant in Core Medical Team), and support local planning, execution quality, prioritization, launch readiness.
• Lead, coach, and develop the CEE+ medical platform team, ensuring clear roles, responsibilities, objectives, KPIs, performance expectations, and development plans.
• Ensure Medical Affairs delivers strong external and internal value through high-quality scientific engagement, impactful field execution, structured insight generation, evidence-based activities, and compliant medical communication.
• Act as a strategic partner to Cross-functional team CEE+ and other Commercial, PACE, RDMA, Regulatory Affairs, Pharmacovigilance, Quality, Geo-Expansion, Portfolio Management, Finance, HR, partner organizations, other functions.
• Represent CEE+ Medical Affairs in relevant regional, global, and local forums, including CEERJ ELT, strategic projects (e.g. Field capabilities); back up line managerinCEE Grant committee, CEERJ LT & workflows ISS, MAP approvals, Veeva
• Ensure governance and compliance across all CEE+ medical activities, including medical plans, deliverables, materials, external interactions, field engagements, partner-market activities, advisory boards, medical education, & cross-functional initiatives

Qualifications

• University degree in a medical-science background or other relevant discipline; medical, clinical or research experience in the assigned disease area is preferred.
• Demonstrated experience in both pre-launch and launch activities, in country and above country, with increasing responsibility.
• Strong track record in  engagement with KOLs locally and internationally.
• Knowledge of health system and healthcare decision-making, including the regulatory, safety, legal and compliance environment.
• Multi-stakeholder project management and leadership experience, delivering on time and within budget
• Proven matrix leadership: influencing affiliates, general managers and global teams without formal authority.
• In-depth people leadership: recruiting, managing and developing a medical team with a performance plan, including coaching across different capability levels and country maturity.
• Personal accountability and ownership, with continuous focus on performance and operational excellence.
• Ability to exchange scientific ideas with KOLs and HCPs and to present scientific data to small and large audiences.
• Ability to quickly build therapeutic area competency of the assigned asset, and ability to oversee other disease areas through the team.
• Experience with evidence generation, publications and scientific dissemination, .
• Experience of reimbursed patient access projects is highly desirable.
• Effective listening skills; ability to work in virtual and multi-disciplinary teams.
• Superior written and verbal communication skills; above-average computer skills.
• Fluency in written and spoken English; other CEE languages are an asset.

Additional Information:

• Frequent regional and international travel is required, approximately 30% of working time.
• Availability for external meetings, congresses and internal meetings outside standard hours with advance notice.
• Valid driver's license may be required depending on local role set-up.
• The role may be home-based or hybrid depending on country, local employment set-up and business requirements.

Additional Information

Here at Sobi, our mission and culture get us excited to come to work every day

Sobi is a global company with over 2000 employees in more than 30 countries and are committed to the societies where we operate. We are a specialised international biopharmaceutical company transforming the lives of people with rare and debilitating diseases, providing reliable access to innovative medicines in the areas of haematology, immunology, and specialty care. Sobi’s share is listed on Nasdaq Stockholm. More about Sobi at sobi.com and LinkedIn.
We know our employees are our most valuable asset and our culture conveys that. We offer a competitive benefits package, to support the health and happiness of our staff.

Sobi Culture

At Sobi, we refuse to accept the status quo. This is because we have witnessed first-hand the challenges facing those affected by rare diseases and have used this knowledge to shape our business to find new ways of helping them.
As a specialized biopharmaceutical company, we are dedicated to rare diseases. And we see this focus as a strength. By effectively turning our research into ground-breaking treatments, we help make medicine more accessible and open more possibilities for patients and more opportunities for those caring for them. This has been our approach since day one, but we know we can’t change the world of rare diseases on our own. Accomplishing this requires strong partnerships with patients, partners and stakeholders across the entire value chain. Together, we define how our business can create solutions that serve the needs of those affected by rare diseases while facilitating sustainable growth.